Dr. Joseph Iser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8648 Yuba Drive, Soda Springs, CA 95728 Phone: 530-426-1336 |
News Archive
A new wave of highly antibiotic resistant superbugs has been found in the Middle East Gulf States, discovered by University of Queensland researchers.
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with recurrent or metastatic castration resistant prostate cancer (IND 209). The trial is being sponsored and conducted by the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario.
The next two weeks of a health reform fight may prove pivotal for President Barack Obama's image and his ability to use his popularity to get things done, The Washington Post reports.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
› Verified 3 days ago